Felzartamab Selectively and Potently Targets CD38+ Antibody-Secreting Cells from Patients with Immune-Mediated Kidney Diseases: SA-PO721
Delfino, Tess Arenzana, Ilieva, Kristina M., Landgraf, Karin, Boxhammer, Rainer, Steidl, Stefan, Flesher, Donna
Published in Journal of the American Society of Nephrology (01.10.2024)
Published in Journal of the American Society of Nephrology (01.10.2024)
Get full text
Journal Article